Quality of Life With Esophageal Stent Trial

NCT ID: NCT01044511

Last Updated: 2011-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or cardia, who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to compare, specialist nurse home visits in patients with inoperable cancer in the esophagus or gastro-esophageal junction (cardia), who are palliated with Self Expanding Metal Stent, to standard patient contact with regards to quality of life, number and character of reinterventions and cost-effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Cancer Gastro-esophageal Junction Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Esophageal cancer Cardia cancer Health Related quality of Life SEMS Home visits

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Home visit

After SEMS placement, 2 home visits and a phonecall are made by a specialist nurse

Group Type EXPERIMENTAL

Home visits

Intervention Type BEHAVIORAL

home visits by specialist nurse 2 times and 1 phonecall

Standard

Standard contact via Hotline and traditional referring methods

Group Type ACTIVE_COMPARATOR

standard

Intervention Type BEHAVIORAL

hotline

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home visits

home visits by specialist nurse 2 times and 1 phonecall

Intervention Type BEHAVIORAL

standard

hotline

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Home visit, pro active nurse care Phone Hotline After hours phone line

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Malignant obstruction of esophagus or cardia treated with SEMS due to non-operable disease.

Exclusion Criteria

* Mentally unable to fill out questionaire
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Odense University Hospital

OTHER

Sponsor Role collaborator

Michael Bau Mortensen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Bau Mortensen

MD, PhD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael B Mortensen, MD,PhD

Role: STUDY_DIRECTOR

Afd A, OUH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Afd A, OUH

Odense, Fyn, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ole Steen Bjerring, MD

Role: CONTACT

Phone: + 45 23 84 06 96

Email: [email protected]

Michael B Mortensen, MD, PhD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bjerring, MD

Role: primary

Mortensen, MD, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QUEST- AFD A

Identifier Type: -

Identifier Source: org_study_id